Holen Sie sich die Stockscreener-App
48.24
2.31%
1.15
Finanzdaten der Crispr Therapeutics Ag-Aktie (CRSP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
2.81%
0.864
|
0.889 | 0.892 | 0.865 | 35.69 |
Operating Expenses
|
17.06%
155.63
|
132.95 | 230.22 | 149.29 | 100.28 |
| Benefits Costs and Expenses |
22.63%
130.86
|
106.71 | 208.15 | 135.75 | 72.30 |
| Costs And Expenses |
22.63%
130.86
|
106.71 | 208.15 | 135.75 | 72.30 |
| Operating Income/Loss |
17.19%
-154.76
|
-132.06 | -229.32 | -148.42 | -64.59 |
| Nonoperating Income/Loss |
5.61%
24.77
|
26.24 | 22.07 | 13.54 | 27.98 |
| Income/Loss From Continuing Operations Before Tax |
22.85%
-130.00
|
-105.82 | -207.26 | -134.89 | -36.61 |
| Income Tax Expense/Benefit |
0.81%
0.614
|
0.619 | 1.292 | 1.109 | 0.70 |
| Income/Loss From Continuing Operations After Tax |
22.71%
-130.61
|
-106.44 | -208.55 | -136.00 | -37.31 |
|
Net Income/Loss
|
22.71%
-130.61
|
-106.44 | -208.55 | -136.00 | -37.31 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
98.03%
1.8009
|
91.31 | 87.07 | 85.94 | 0.3711 |
| Diluted Average Shares |
98.03%
1.8009
|
91.31 | 87.07 | 85.94 | 0.3711 |
| Basic Earnings Per Share |
15.38%
-1.35
|
-1.17 | -2.40 | -1.58 | -0.42 |
| Diluted Earnings Per Share |
15.38%
-1.35
|
-1.17 | -2.40 | -1.58 | -0.42 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.99%
3.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):